News

Norman Parathyroid Center's Initiative to Combat Hyperparathyroidism

Norman Parathyroid Center's Initiative to Combat Hyperparathyroidism

Norman Parathyroid Center's New Awareness Campaign

In a groundbreaking move to raise awareness for hyperparathyroidism, the Norman Parathyroid Center is thrilled to announce the launch of the first-ever Hyperparathyroidism Awareness Day. This initiative coincides with Parathyroid Awareness Month and aims to shed light on a condition that affects a significant number of people, particularly women over 50. The center, renowned for its specialized treatment of parathyroid disorders, is dedicated to improving the lives of those affected by this often-misunderstood condition.

Partnership with Any Lab Test Now

To enhance diagnostic capabilities, the Norman Parathyroid Center has formed a national partnership with Any Lab Test Now. This collaboration is designed to facilitate easy access to essential lab tests that help in diagnosing hyperparathyroidism. The newly introduced Parathyroid Health Panel is now available at over 240 Any Lab Test Now locations nationwide. This panel includes crucial tests for blood calcium and parathyroid hormone (PTH) levels—key indicators for diagnosing this endocrine disorder.

Understanding the Importance of Awareness

The establishment of Hyperparathyroidism Awareness Day marks a significant step towards educating the public about this condition, which is frequently overlooked. Dr. Jim Norman, founder of the Norman Parathyroid Center, emphasizes that hyperparathyroidism is prevalent, yet often goes undiagnosed due to a lack of awareness and understanding among healthcare providers. The center's extensive experience treating over 60,000 patients with this disease highlights the need for increased educational efforts.

The Challenges of Diagnosis

Challenges in diagnosing hyperparathyroidism stem from misunderstood lab values, particularly calcium levels. For adults over 40, a calcium level above 10.0 mg/dL is considered abnormal. Unfortunately, many healthcare professionals mistakenly accept levels up to 10.5 mg/dL as normal, leading to a significant number of undiagnosed cases. By better educating both patients and doctors about the implications of these lab results, the Norman Parathyroid Center hopes to reduce the time patients spend suffering from this curable condition.

Potential Symptoms of Hyperparathyroidism

Hyperparathyroidism can manifest in various ways, and its symptoms are often mistaken for common signs of aging, which can delay proper treatment. Common symptoms include:

  • Bone loss and increased risk of osteoporosis
  • Kidney stones
  • Fatigue and cognitive difficulties, such as memory loss
  • High blood pressure along with heart palpitations
  • Changes in mood, anxiety, and depression

Patients frequently report seeing a remarkable improvement in their health following a surgical procedure to remove the overactive gland(s). Many feel rejuvenated, claiming they feel considerably younger in just a short time post-surgery.

The Role of the Parathyroid Health Panel

The Parathyroid Health Panel represents a significant advancement in the effort to diagnose primary hyperparathyroidism. It requires no doctor's referral, allowing patients the freedom to walk into any participating location without prior appointments. This initiative empowers individuals to take charge of their health and seek immediate testing if they suspect they may have this condition.

Moving Forward

People experiencing abnormal lab results are encouraged to explore further evaluation and treatment at the Norman Parathyroid Center. The center is known for its high success rates, performing nearly 3,800 parathyroid surgeries each year with a remarkable cure rate of over 99%. The team of skilled surgeons is committed to providing comprehensive care with a focus on teamwork and patient outcomes.

About the Norman Parathyroid Center

The Norman Parathyroid Center is recognized as the world's leading treatment facility for parathyroid gland tumors. The center specializes in parathyroid surgery, which typically lasts just around 20 minutes. This efficient procedure has empowered thousands to reclaim their health and vitality.

# About the Hospital for Endocrine Surgery
The Hospital for Endocrine Surgery is the premier institution for endocrine surgical care. It integrates various specialties including the Norman Parathyroid Center and continues to innovate within the field, having seen over 20,000 new patient consultations in just two years.

Frequently Asked Questions

What is Hyperparathyroidism?

Hyperparathyroidism is a condition caused by overactive parathyroid glands, leading to elevated calcium levels in the blood.

How can I get tested for Hyperparathyroidism?

The Parathyroid Health Panel is available at Any Lab Test Now locations, and you can walk in without needing a doctor’s referral.

What are common symptoms of Hyperparathyroidism?

Symptoms can include fatigue, kidney stones, bone loss, and mood swings, among others.

Is Hyperparathyroidism treatable?

Yes, it is typically treated through a minimally invasive outpatient surgery that offers high cure rates.

Who can I contact for more information?

For inquiries, you can contact the Norman Parathyroid Center directly for guidance on getting tested or treated.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sky Labs' CART Monitor Advances BP Monitoring Tech

Updated Category News Views 3

Cuffless BP Monitoring: Changing the Game for AF and HF Ever thought a finger ring could revolutionize blood pressure monitoring? Well, welcome to the future—Sky Labs' ring-type CART monitor has just rocked the scene at the ESC Congress 2026 in Munich. This isn't sci-fi, folks; it's where health tech meets reality, and it's shaking the very foundations of how we manage...

Continue Reading
EQT Wraps Up Share Buyback with 4.3M Shares Repurchased

Updated Category News Views 1

EQT's Bold Buyback: Crunching the Numbers Alright, let's peel back the curtain on EQT's latest maneuver—finishing up their share buyback program, all neat and tidy for 2026. They nailed down 707,203 of their own shares just in the first week of September, part of a grand total of 4,368,899 snatched up in the entire effort. That's a whopping SEK 1.448 billion invested in...

Continue Reading
Hyosung Targets U.S. AI Power Market with Advanced SST

Updated Category News Views 1

Hyosung's Game-Changing Move in the AI Power Sector Guess what? The AI era's heating up, and it's dragging the power sector along for a wild ride. Hyosung Chairman Hyun-Joon Cho peered into that future and decided it's all-in time for the U.S. power market. With AI and data centers cranking up power demands like never before, those rickety old wires need an upgrade fast....

Continue Reading
Stem Cell Market Set for Major Gains to 2031

Updated Category News Views 1

Stem Cells: The Next Frontier or Hype? Folks, stem cells are no longer just a sci-fi concept tucked away in lab coats. This sector's set to boom from USD 18.9 billion in 2026 to a whopping USD 32.57 billion by 2031. Yeah, you heard it right, a solid 11.5% compound annual growth rate. Now, whether you're an investor or just keeping your finger on the biotech pulse, there's...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 5

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Consumer365 Highlights Happy Head's Personalized Hair Solutions

Updated Category News Views 1

Tailored Hair Loss Solutions by Happy Head Imagine trying to fit a square peg in a round hole. That's what one-size-fits-all approaches often feel like in the world of hair loss treatments. Happy Head, recognized by Consumer365, takes that notion and turns it on its head, offering personalized minoxidil formulations for women. The key word here is personalized. More Than...

Continue Reading
Beazer Homes Sale Scrutinized for Shareholder Impact

Updated Category News Views 1

Spotlight on Beazer Homes' Proposed Sale Here's a real head-scratcher for folks in the stock trenches: Beazer Homes USA, Inc. (NYSE: BZH) finds itself under the microscope with Halper Sadeh LLC stirring the pot. You can't make this up—just another day in the world of investor rights and looming litigation. Questions Arise Over Shareholder Gains Halper Sadeh LLC, that...

Continue Reading
Lida Group Expands Global Modular Construction Services

Updated Category News Views 5

Modular Construction's Expanding Footprint Behold Lida Group—a titan in the world of modular construction—taking ambitious strides into the global arena, reaching from the sand dunes of Saudi Arabia to the bustling corridors of the United Nations. If you haven't been paying attention, now's the time to get your head in the game. Their expansion isn't just about...

Continue Reading
CABP Market Sees Potential in New Treatments Rising

Updated Category News Views 2

Rising Threats and New Solutions in CABP Market Listen up, folks. The community-acquired bacterial pneumonia (CABP) market is set to swell. And why is that? Well, it's got everything to do with a growing disease burden, aging populations, and complications from comorbid conditions. But here's the kicker: antimicrobial resistance is climbing like a cat up a tree, and that...

Continue Reading
UST Grabs Italdesign: Driving Future Mobility with AI

Updated Category News Views 3

UST's Strategic Move Into Automotive's Future Wake up and smell the coffee, because UST is shaking up the automotive scene. They've just pulled off a major play by grabbing a majority stake in Italdesign. If that doesn't scream the next leap forward for the auto world, I don't know what does. UST isn't just buying a company; it's marrying Italdesign's legendary design...

Continue Reading

Top 5 Most Recently Viewed Articles

Precision BioSciences Expands Leadership Team for Growth

Updated Category News Views 134

Precision BioSciences Expands Leadership Team for Growth Precision BioSciences, Inc. (Nasdaq: DTIL), a pioneering clinical-stage gene editing company, has made significant changes to its senior leadership team as it aims to advance its in vivo gene editing programs, including the promising PBGENE-HBV project currently in Phase 1 clinical studies. Strategic Leadership...

Continue Reading
Understanding Qualcomm's Short Interest Trends and Implications

Updated Category News Views 201

Qualcomm Short Interest Overview Qualcomm (QCOM) has recently reported a significant decrease in its short percent of float, which has dropped by 9.4% since the last report. Currently, there are 21.02 million shares sold short, representing 2.12% of the company's total regular shares available for trading. Based on recent trading volumes, it would take approximately 2.25...

Continue Reading
Simply Good Foods Company Delivers Strong Q1 Performance

Updated Category News Views 117

Simply Good Foods Company Shows Positive Growth Simply Good Foods Company (NASDAQ: SMPL), a leader in the nutrition snack industry, has reported impressive financial results for its fiscal first quarter, ending November 30, 2024. This period marks a significant year-over-year improvement in sales and profitability. Financial Highlights of Q1 2025 Impressive Sales and...

Continue Reading
Denmark's Bold Move to Safeguard Personal Identity Rights Against AI

Updated Category News Views 272

Denmark's Progressive Stance on Deepfake Technology Denmark is taking a significant step in the realm of digital privacy by updating its copyright laws to safeguard individual rights against deepfake technology. This innovative move allows citizens to have legal ownership of their own faces, voices, and bodies. In a world where AI-generated imitations are becoming...

Continue Reading
Spotlight Biographees: Celebrating Remarkable Achievements

Updated Category News Views 284

Spotlight Biographees: Celebrating Remarkable Achievements The Spotlight Series highlights the impressive resumes and career accomplishments of hand-selected professionals. Marquis Who's Who (MWW), the leading biographical publisher globally, proudly acknowledges a diverse group of professionals recognized in the Spotlight Series for their outstanding contributions. This...

Continue Reading